Conjunctival in-vivo cellular imaging method using fluoroquinolone antibiotics, method for providing information on ocular lesions using the same, method for detecting the efficacy of ocular lesion therapeutics

Method and Device for Conjunctival In-Vivo Cellular Imaging Using Fluoroquinolone Antibiotics

This technology is a conjunctival in-vivo cellular imaging method and device that stains and fluorescently images conjunctival goblet cells using fluoroquinolone antibiotics such as moxifloxacin, and a method for providing ocular lesion information using this technology.

Existing goblet cell diagnostic methods had limitations, as they caused conjunctival damage and provided low-contrast images.

This technology uses single-photon excitation fluorescence imaging to obtain high-contrast images of goblet cells without causing conjunctival damage, and is utilized for ocular lesion detection and therapeutic efficacy evaluation.

‍

‍

Key Features:

• Staining of conjunctival goblet cells using fluoroquinolone antibiotics
• Light illumination step by the light source
• Single-photon excitation fluorescence imaging
• Provision of ocular lesion information without conjunctival damage